Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07546513 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Cistanche Supplementation on Anaerobic Exercise Performance and Recovery in Men With Different Athletic Training Levels

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Completed without a posted recruiting period
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: details revised at 8 of 10 entries
    • Publications: details revised at 13 of 15 entries
  2. Notable Start date: Nov 20, 2025 to Jun 25, 2026
    • Trial status: Completed to Not Yet Recruiting
    • Primary completion date: Apr 1, 2026 to Sep 1, 2026
    • Study completion date: Apr 12, 2026 to Sep 15, 2026
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a double-blind, randomized, placebo-controlled trial designed to examine whether 8 weeks of Cistanche deserticola supplementation, when combined with a standardized anaerobic training program, can improve anaerobic exercise performance, recovery, and selected body composition outcomes in young adult men with different athletic training levels. Participants will be assigned to receive either Cistanche deserticola extract or a matched placebo while completing the same supervised anaerobic training program. The study will assess changes in anaerobic performance, including Wingate test outcomes and jump performance, as well as recovery-related indicators such as blood lactate, creatine kinase, malondialdehyde, testosterone, cortisol, and the testosterone-to-cortisol ratio. Body composition outcomes, including body fat percentage and skeletal muscle mass, will also be evaluated. The purpose of this study is to determine whether Cistanche deserticola supplementation provides additional benefits beyond training alone, and whether these effects differ between highly trained and recreationally trained participants.
Trial Details
NCT Number NCT07546513
Lead Sponsor Beijing Sport University
Collaborators: Wuhan Sports University
Conditions
(from sponsor)
Athlete, Elite Athlete, Sport Performance, Exercise Recovery
Enrollment 56 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov